Zhao Zhi-Hao, Zhang Ding-Kun, Wu Ming-Quan, Li Chun-Yu, Cao Li-Juan, Zhang Ping, Liu Cui-Zhe, Wang Jia-Bo, Xiao Xiao-He
Chengde Medical College, Chengde 067000, China.
Research Institute of Kidney Disease, Nanjing University of Chinese Medicine, Nanjing 210029, China.
Zhongguo Zhong Yao Za Zhi. 2016 Oct;41(20):3814-3820. doi: 10.4268/cjcmm20162017.
Aconiti Lateralis Radix (Fuzi) is a toxic traditional Chinese medicine with definite efficacy. In order to improve the quality control of its different prepared products and ensure the security in clinic, it is significant to establish a method of quality evaluation related to clinic adverse effects. Aiming at the important biological marker of early cardiac toxicity reaction, there was no method to detect it. In this manuscript, a novel approach for measuring the minimal toxic dose (MTD) of premature ventricular contractions (PVC) poisoning of rats was established. Then, the determination methodology and conditions were optimized to meet the needs of the quality and biological assessment, including animal sex, weight, stability of standards and test solutions. Using this method, the MTD value of different Fuzi products were determined, such as Heishunpian, Baifupian, Zhengfupian, Baofupian, and Paotianxiong. The results showed that the MTD of Fuzi was significantly decreased after detoxification processed (P<0.05) and the MTD of Heishunpian, Zhengfupian, Baofupian and Baifupian was as much as 15.76, 22.36, 19.65 and 20.97 times to that of unprocessed Shengfuzi. In addition, Paotianxiong could not induce PVC in rats, which indicated that Paotianxiong was nontoxic and safe.This method could appropriately reflects the cardiotoxity of Fuzi and its prepared samples. Together with the chemical composition analysis, the contents of diester alkaloids were explored including aconitine, mesaconitine and hypaconitine as well as monoester alkaloids in Fuzi and its prepared products were significantly associated with PVC. Furthermore, there may be some components undetermined facilitating arrhythmia to be worth exploring. This research provides an overall and comprehensive approach to diagnose early clinical cardiotoxity and control the quality of Fuzi, which could not only be a complementary solution for the chemical evaluation, but a new method to ensure its efficacy and security of clinical application.
附子是一种疗效确切的有毒中药。为提高其不同炮制品的质量控制水平并确保临床用药安全,建立与临床不良反应相关的质量评价方法具有重要意义。针对早期心脏毒性反应的重要生物标志物,尚无检测方法。本文建立了一种测定大鼠室性早搏(PVC)中毒最小中毒剂量(MTD)的新方法。然后,对测定方法和条件进行优化以满足质量和生物学评价的需求,包括动物性别、体重、标准品和供试品溶液的稳定性等。采用该方法测定了不同附子炮制品(如黑顺片、白附片、正附片、保附片和炮天雄)的MTD值。结果表明,附子经炮制后MTD显著降低(P<0.05),黑顺片、正附片、保附片和白附片的MTD分别是未炮制生附子的15.76、22.36、19.65和20.97倍。此外,炮天雄未引起大鼠PVC,表明炮天雄无毒安全。该方法能较好地反映附子及其炮制品的心脏毒性。结合化学成分分析,探讨了附子及其炮制品中双酯型生物碱(如乌头碱、中乌头碱和次乌头碱)以及单酯型生物碱的含量与PVC显著相关。此外,可能存在一些未确定的成分促进心律失常,值得进一步探索。本研究为早期临床心脏毒性诊断和附子质量控制提供了一种全面综合的方法,不仅可作为化学评价的补充手段,也是确保其临床应用有效性和安全性的新方法。